The K153R variant in the myostatin gene and sarcopenia at the end of the human lifespan

Age

Volumn 32, Issue 3, 2010, Pages 405-409

  González Freire, Marta ^a   Rodríguez Romo, Gabriel ^b   Santiago, Catalina ^a   Bustamante Ara, Natalia ^a   Yvert, Thomas ^a   Gómez Gallego, Félix ^a   Serra Rexach, José A ^c   Ruiz, Jonatan R ^d   Lucia, Alejandro ^a  

^a UNIVERSIDAD EUROPEA DE MADRID   (Spain)

^b UNIVERSIDAD POLITÉCNICA DE MADRID   (Spain)

^c HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Activities of daily living; GDF 8; Muscle strength; Nonagenarians

Indexed keywords

ARGININE; LYSINE; MYOSTATIN;

AGED; ALLELE; ARTICLE; CAUCASIAN; CLINICAL ARTICLE; CONTROLLED STUDY; DAILY LIFE ACTIVITY; FEMALE; FUNCTIONAL STATUS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOSITY; HUMAN; LIFESPAN; MALE; MUSCLE ATROPHY; MUSCLE FUNCTION; MUSCLE MASS; MUSCLE STRENGTH; PHENOTYPE;

ACTIVITIES OF DAILY LIVING; AGED, 80 AND OVER; FEMALE; HUMANS; MYOSTATIN; PHENOTYPE; POLYMORPHISM, GENETIC; SARCOPENIA;

EID: 77956186674     PISSN: 01619152     EISSN: 15744647     Source Type: Journal    
DOI: 10.1007/s11357-010-9139-7     Document Type: Article

References (24)

1. SV Brooks JA Faulkner 1994 Skeletal muscle weakness in old age: underlying mechanisms Med Sci Sports Exerc 26 432 439 1:STN:280: DyaK2c3mtVyqtQ%3D%3D 8201898
2. M Brzycki 1993 Strength testing: predicting a one-rep max from repetitions to fatigue JOPERD 64 88 90
3. C Collin DT Wade S Davies V Hoene 1988 The Barthel ADL Index: a reliability study Int Disabil Stud 10 61 63 1:STN:280:DyaL1c3pvVKhsQ%3D%3D 3403500
4. AM Corsi L Ferrucci A Gozzini A Tanini ML Brandi 2002 Myostatin polymorphisms and age-related sarcopenia in the Italian population J Am Geriatr Soc 50 1463 10.1046/j.1532-5415.2002.50376.x 12165013
5. RE Ferrell V Conte EC Lawrence SM Roth JM Hagberg BF Hurley 1999 Frequent sequence variation in the human myostatin (GDF8) gene as a marker for analysis of muscle-related phenotypes Genomics 62 203 207 10.1006/geno.1999.5984 1:CAS:528:DyaK1MXotFektL8%3D 10610713
6. M Gonzalez-Freire C Santiago F Gomez-Gallego M Perez C Foster J Arenas A Lucia 2009 Does the K153R variant of the myostatin gene influence the clinical presentation of women with McArdle disease? Neuromuscul Disord 19 220 222 10.1016/j.nmd.2009.01.001 19232494
7. W Huygens MA Thomis MW Peeters J Aerssens R Janssen RF Vlietinck G Beunen 2004 Linkage of myostatin pathway genes with knee strength in humans Physiol Genomics 17 264 270 10.1152/physiolgenomics.00224.2003 1:CAS:528: DC%2BD2cXltVSkurY%3D 15026560
8. MS Jiang LF Liang S Wang T Ratovitski J Holmstrom C Barker R Stotish 2004 Characterization and identification of the inhibitory domain of GDF-8 propeptide Biochem Biophys Res Commun 315 525 531 10.1016/j.bbrc.2004.01.085 1:CAS:528:DC%2BD2cXht1yisLg%3D 14975732
9. P Juffer R Furrer M González-Freire C Santiago Z Verde L Serratosa FJ Morate JC Rubio MA Martin JR Ruiz J Arenas F Gómez-Gallego A Lucia 2009 Genotype distributions in top-level soccer players: a role for ACE? Int J Sports Med 30 387 392 10.1055/s-0028-1105931 1:CAS:528:DC%2BD1MXmsVertr4%3D 19277943
10. MA Kostek TJ Angelopoulos PM Clarkson PM Gordon NM Moyna PS Visich RF Zoeller TB Price RL Seip PD Thompson JM Devaney H Gordish-Dressman EP Hoffman LS Pescatello 2009 Myostatin and follistatin polymorphisms interact with muscle phenotypes and ethnicity Med Sci Sports Exerc 41 1063 1071 10.1249/MSS. 0b013e3181930337 1:CAS:528:DC%2BD1MXntFyqt7g%3D 19346981
11. SJ Lee AC McPherron 2001 Regulation of myostatin activity and muscle growth Proc Natl Acad Sci U S A 98 9306 9311 10.1073/pnas.151270098 1:CAS:528:DC%2BD3MXlvFSrsL0%3D 11459935
12. RC Lee Z Wang M Heo R Ross I Janssen SB Heymsfield 2000 Total-body skeletal muscle mass: development and cross-validation of anthropometric prediction models Am J Clin Nutr 72 796 803 1:CAS:528:DC%2BD3cXmsFGrt7w%3D 10966902
13. FI Mahoney DW Barthel 1965 Functional evaluation: the Barthel Index Md State Med J 14 61 65 1:STN:280:DyaF2M%2FmtlCltA%3D%3D 14258950
14. AC McPherron AM Lawler SJ Lee 1997 Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member Nature 387 83 90 10.1038/387083a0 1:CAS:528:DyaK2sXivFygur0%3D 9139826
15. M Raiche R Hebert F Prince H Corriveau 2000 Screening older adults at risk of falling with the Tinetti balance scale Lancet 356 1001 1002 10.1016/S0140-6736(00)02695-7 1:STN:280:DC%2BD3cvptVWgsA%3D%3D 11041405
16. R Ríos I Carneiro VM Arce J Devesa 2002 Myostatin is an inhibitor of myogenic differentiation Am J Physiol Cell Physiol 282 C993 C999 11940514
17. MA Saunders JM Good EC Lawrence RE Ferrell WH Li MW Nachman 2006 Human adaptive evolution at Myostatin (GDF8), a regulator of muscle growth Am J Hum Genet 79 1089 1097 10.1086/509707 1:CAS:528:DC%2BD28Xht1yksr%2FP 17186467
18. MJ Seibert QL Xue LP Fried JD Walston 2001 Polymorphic variation in the human myostatin (GDF-8) gene and association with strength measures in the Women's Health and Aging Study II cohort J Am Geriatr Soc 49 1093 1096 10.1046/j.1532-5415.2001.49214.x 1:STN:280:DC%2BD3Mrgs12rtw%3D%3D 11555072
19. JA Serra Rexach JR Ruiz N Bustamante-Ara MH Villaran PG Gil MJ Sanz Ibanez NB Sanz VO Santamaria NG Sanz AB Prada C Gallardo GR Romo A Lucia 2009 Health enhancing strength training in nonagenarians (STRONG): rationale, design and methods BMC Public Health 9 152 10.1186/1471-2458-9-152 19470176
20. V Siriett L Platt MS Salerno N Ling R Kambadur M Sharma 2006 Prolonged absence of myostatin reduces sarcopenia J Cell Physiol 209 866 873 10.1002/jcp.20778 1:CAS:528:DC%2BD28XhtFOktLjM 16972257
21. M Thomas B Langley C Berry M Sharma S Kirk J Bass R Kambadur 2000 Myostatin, a negative regulator of muscle growth, functions by inhibiting myoblast proliferation J Biol Chem 275 40235 40243 10.1074/jbc.M004356200 1:CAS:528:DC%2BD3MXhsFemuw%3D%3D 10976104
22. ME Tinetti 1986 Performance-oriented assessment of mobility problems in elderly patients J Am Geriatr Soc 34 119 126 1:STN:280:DyaL287htlSntg%3D%3D 3944402
23. PT van Dijk DR Mehr ME Ooms R Madsen G Petroski DH Frijters AM Pot MW Ribbe 2005 Comorbidity and 1-year mortality risks in nursing home residents J Am Geriatr Soc 53 660 665 10.1111/j.1532-5415.2005.53216.x 15817014
24. KR Wagner JL Fleckenstein AA Amato RJ Barohn K Bushby DM Escolar KM Flanigan A Pestronk R Tawil GI Wolfe M Eagle JM Florence WM King S Pandya V Straub P Juneau K Meyers C Csimma T Araujo R Allen SA Parsons JM Wozney ER Lavallie JR Mendell 2008 A phase I/IItrial of MYO-029 in adult subjects with muscular dystrophy Ann Neurol 63 561 571 10.1002/ana.21338 1:CAS:528: DC%2BD1cXntFyrtrs%3D 18335515